Halozyme Therapeutics Inc. (HALO) Financial Statements (2026 and earlier)

Company Profile

Business Address 12390 EL CAMINO REAL
SAN DIEGO, CA 92130
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments133,820115,850118,370362,794740,922368,013
Cash and cash equivalent133,820115,850118,370234,195118,719147,703
Short-term investments    128,599622,203220,310
Receivables426,273288,204 231,07290,97597,730
Inventory, net of allowances, customer advances and progress billings176,475141,860127,601100,12353,90860,747
Inventory176,475141,860127,601100,12353,90860,747
Prepaid expense71,92536,31736,850   
Contract with customer, asset, after allowance for credit loss  20,3001,000   
Derivative instruments and hedges, assets 2,400    
Other undisclosed current assets16,714480,409462,60345,02440,48228,274
Total current assets:825,2071,085,340746,424739,013926,287554,764
Noncurrent Assets
Inventory, Noncurrent20,76855,268    
Operating lease, right-of-use asset37,69534,17136,83640,4692,003 
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization44,44240,86438,10835,1016,79110,593
Intangible asset, including goodwill, after accumulated amortization1,561,827818,651889,700955,701  
Goodwill580,360416,821416,821409,049  
Intangible asset, excluding goodwill, after accumulated amortization981,467401,830472,879546,652  
Derivative instruments and hedges 1,600    
Restricted cash and investments2,601  500500500
Deferred income tax assets  3,8554,38644,426155,434 
Other undisclosed noncurrent assets32,78323,72817,81626,30113,41414,067
Total noncurrent assets:1,700,116978,137986,8461,102,498178,14225,160
TOTAL ASSETS:2,525,3232,063,4771,733,2701,841,5111,104,429579,924
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities177,092139,100112,494114,20925,98222,411
Accounts payable20,89910,24911,81617,6931,5411,928
Accrued liabilities156,193128,851100,67896,51624,44120,483
Deferred revenue    3,2461,7461,746
Debt   13,33489,419397,228
Total current liabilities:177,092139,100112,494130,789117,147421,385
Noncurrent Liabilities
Long-term debt and lease obligation2,142,6301,505,7981,499,2481,492,766787,255 
Long-term debt, excluding current maturities2,142,6301,505,7981,499,2481,492,766787,255 
Liabilities, other than long-term debt156,78754,75837,72048,1583,0747,492
Deferred revenue    2,2532,5304,026
Deferred income tax liabilities42,924     
Other liabilities113,86354,75837,72030,4335443,466
Business combination, contingent consideration, liability    15,472  
Total noncurrent liabilities:2,299,4171,560,5561,536,9681,540,924790,3297,492
Total liabilities:2,476,5091,699,6561,649,4621,671,713907,476428,877
Equity
Equity, attributable to parent48,814363,82183,808169,798196,953151,047
Common stock118123127135138135
Additional paid in capital12,002 2,40927,368256,347625,483
Accumulated other comprehensive income (loss)(18,092)3,829(9,278)(922)(620)22
Retained earnings (accumulated deficit)54,786359,86990,550143,217(58,912)(474,593)
Total equity:48,814363,82183,808169,798196,953151,047
TOTAL LIABILITIES AND EQUITY:2,525,3232,063,4771,733,2701,841,5111,104,429579,924

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenues1,396,6111,015,324829,253660,116443,310267,594
Cost of revenue
(Cost of Product and Service Sold)		(228,774)(159,417)(192,361)(139,304)(81,413)(43,367)
Gross profit:1,167,837855,907636,892520,812361,897224,227
Operating expenses(698,831)(304,432)(299,318)(253,281)(85,995)(79,972)
Operating income:469,006551,475337,574267,531275,902144,255
Nonoperating income
(Other Nonoperating income)		21,47223,75216,3171,0461,1025,425
Interest and debt expense(23,603)(18,095)(18,762)(19,659)(28,486)(20,378)
Income from continuing operations before equity method investments, income taxes:466,875557,132335,129248,918248,518129,302
Other undisclosed income from continuing operations before income taxes   13,200   
Income from continuing operations before income taxes:466,875557,132348,329248,918248,518129,302
Income tax expense (benefit)(149,986)(113,041)(66,735)(46,789)154,192(217)
Income from continuing operations:316,889444,091281,594202,129402,710129,085
Income before gain (loss) on sale of properties:✕✕✕✕✕402,710129,085
Net income available to common stockholders, diluted:316,889444,091281,594202,129402,710129,085

Comprehensive Income ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net income:316,889444,091281,594202,129402,710129,085
Other comprehensive income (loss)(21,921)13,10724815(32)
Comprehensive income:294,968457,198281,618202,137402,725129,053
Other undisclosed comprehensive loss, net of tax, attributable to parent   (8,380)(310)(657)(186)
Comprehensive income, net of tax, attributable to parent:294,968457,198273,238201,827402,068128,867

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: